Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Several behavioral traits relevant for alcoholism are controlled by ɣ2 subunit containing GABAA receptors on dopamine neurons in mice.

Stojakovic A, Walczak M, Cieślak PE, Trenk A, Sköld J, Zajdel J, Mirrasekhian E, Karlsson C, Thorsell A, Heilig M, Parkitna JR, Błasiak T, Engblom D.

Neuropsychopharmacology. 2018 Jun;43(7):1548-1556. doi: 10.1038/s41386-018-0022-z. Epub 2018 Feb 5.

2.

Loss of NMDA receptors in dopamine neurons leads to the development of affective disorder-like symptoms in mice.

Jastrzębska K, Walczak M, Cieślak PE, Szumiec Ł, Turbasa M, Engblom D, Błasiak T, Parkitna JR.

Sci Rep. 2016 Nov 17;6:37171. doi: 10.1038/srep37171.

3.

Prostaglandin-dependent modulation of dopaminergic neurotransmission elicits inflammation-induced aversion in mice.

Fritz M, Klawonn AM, Nilsson A, Singh AK, Zajdel J, Wilhelms DB, Lazarus M, Löfberg A, Jaarola M, Kugelberg UÖ, Billiar TR, Hackam DJ, Sodhi CP, Breyer MD, Jakobsson J, Schwaninger M, Schütz G, Parkitna JR, Saper CB, Blomqvist A, Engblom D.

J Clin Invest. 2016 Feb;126(2):695-705.

4.

CREB activity in dopamine D1 receptor expressing neurons regulates cocaine-induced behavioral effects.

Bilbao A, Rieker C, Cannella N, Parlato R, Golda S, Piechota M, Korostynski M, Engblom D, Przewlocki R, Schütz G, Spanagel R, Parkitna JR.

Front Behav Neurosci. 2014 Jun 11;8:212. doi: 10.3389/fnbeh.2014.00212. eCollection 2014. Erratum in: Front Behav Neurosci. 2014;8:239. Front Behav Neurosci. 2014;8:239.

5.

A model of alcohol drinking under an intermittent access schedule using group-housed mice.

Smutek M, Turbasa M, Sikora M, Piechota M, Zajdel J, Przewlocki R, Parkitna JR.

PLoS One. 2014 May 7;9(5):e96787. doi: 10.1371/journal.pone.0096787. eCollection 2014.

6.

Novelty-seeking behaviors and the escalation of alcohol drinking after abstinence in mice are controlled by metabotropic glutamate receptor 5 on neurons expressing dopamine d1 receptors.

Parkitna JR, Sikora M, Gołda S, Gołembiowska K, Bystrowska B, Engblom D, Bilbao A, Przewlocki R.

Biol Psychiatry. 2013 Feb 1;73(3):263-70. doi: 10.1016/j.biopsych.2012.07.019. Epub 2012 Aug 16.

PMID:
22902169
7.

Ablation of serum response factor in dopaminergic neurons exacerbates susceptibility towards MPTP-induced oxidative stress.

Rieker C, Schober A, Bilbao A, Schütz G, Parkitna JR.

Eur J Neurosci. 2012 Mar;35(5):735-41. doi: 10.1111/j.1460-9568.2012.08003.x. Epub 2012 Feb 22.

PMID:
22356487
8.

Glutamate input to noradrenergic neurons plays an essential role in the development of morphine dependence and psychomotor sensitization.

Parkitna JR, Solecki W, Gołembiowska K, Tokarski K, Kubik J, Gołda S, Novak M, Parlato R, Hess G, Sprengel R, Przewłocki R.

Int J Neuropsychopharmacol. 2012 Nov;15(10):1457-71. doi: 10.1017/S1461145711001568. Epub 2011 Nov 1.

PMID:
22040728
9.

Glucocorticoid activity during lung maturation is essential in mesenchymal and less in alveolar epithelial cells.

Habermehl D, Parkitna JR, Kaden S, Brügger B, Wieland F, Gröne HJ, Schütz G.

Mol Endocrinol. 2011 Aug;25(8):1280-8. doi: 10.1210/me.2009-0380. Epub 2011 Jun 9.

10.

MicroRNA loss enhances learning and memory in mice.

Konopka W, Kiryk A, Novak M, Herwerth M, Parkitna JR, Wawrzyniak M, Kowarsch A, Michaluk P, Dzwonek J, Arnsperger T, Wilczynski G, Merkenschlager M, Theis FJ, Köhr G, Kaczmarek L, Schütz G.

J Neurosci. 2010 Nov 3;30(44):14835-42. doi: 10.1523/JNEUROSCI.3030-10.2010.

11.

Effects of the cell type-specific ablation of the cAMP-responsive transcription factor in noradrenergic neurons on locus coeruleus firing and withdrawal behavior after chronic exposure to morphine.

Parlato R, Cruz H, Otto C, Murtra P, Parkitna JR, Martin M, Bura SA, Begus-Nahrmann Y, von Bohlen und Halbach O, Maldonado R, Schütz G, Lüscher C.

J Neurochem. 2010 Nov;115(3):563-73. doi: 10.1111/j.1471-4159.2010.06709.x. Epub 2010 Aug 19.

12.

Loss of the serum response factor in the dopamine system leads to hyperactivity.

Parkitna JR, Bilbao A, Rieker C, Engblom D, Piechota M, Nordheim A, Spanagel R, Schütz G.

FASEB J. 2010 Jul;24(7):2427-35. doi: 10.1096/fj.09-151423. Epub 2010 Mar 11.

PMID:
20223941
13.

Cocaine-evoked synaptic plasticity: persistence in the VTA triggers adaptations in the NAc.

Mameli M, Halbout B, Creton C, Engblom D, Parkitna JR, Spanagel R, Lüscher C.

Nat Neurosci. 2009 Aug;12(8):1036-41. doi: 10.1038/nn.2367. Epub 2009 Jul 13.

PMID:
19597494
14.

Generation of Cre recombinase-expressing transgenic mice using bacterial artificial chromosomes.

Parkitna JR, Engblom D, Schütz G.

Methods Mol Biol. 2009;530:325-42. doi: 10.1007/978-1-59745-471-1_17.

PMID:
19266340
15.

Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain.

Obara I, Parkitna JR, Korostynski M, Makuch W, Kaminska D, Przewlocka B, Przewlocki R.

Pain. 2009 Feb;141(3):283-91. doi: 10.1016/j.pain.2008.12.006. Epub 2009 Jan 14.

PMID:
19147290
16.

Loss of the Ca2+/calmodulin-dependent protein kinase type IV in dopaminoceptive neurons enhances behavioral effects of cocaine.

Bilbao A, Parkitna JR, Engblom D, Perreau-Lenz S, Sanchis-Segura C, Schneider M, Konopka W, Westphal M, Breen G, Desrivieres S, Klugmann M, Guindalini C, Vallada H, Laranjeira R, de Fonseca FR, Schumann G, Schütz G, Spanagel R.

Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17549-54. doi: 10.1073/pnas.0803959105. Epub 2008 Nov 10.

17.

Glutamate receptors on dopamine neurons control the persistence of cocaine seeking.

Engblom D, Bilbao A, Sanchis-Segura C, Dahan L, Perreau-Lenz S, Balland B, Parkitna JR, Luján R, Halbout B, Mameli M, Parlato R, Sprengel R, Lüscher C, Schütz G, Spanagel R.

Neuron. 2008 Aug 14;59(3):497-508. doi: 10.1016/j.neuron.2008.07.010.

18.

CREB has a context-dependent role in activity-regulated transcription and maintains neuronal cholesterol homeostasis.

Lemberger T, Parkitna JR, Chai M, Schütz G, Engblom D.

FASEB J. 2008 Aug;22(8):2872-9. doi: 10.1096/fj.08-107888. Epub 2008 Apr 18.

PMID:
18424767
19.

Effects of glycogen synthase kinase 3beta and cyclin-dependent kinase 5 inhibitors on morphine-induced analgesia and tolerance in rats.

Parkitna JR, Obara I, Wawrzczak-Bargiela A, Makuch W, Przewlocka B, Przewlocki R.

J Pharmacol Exp Ther. 2006 Nov;319(2):832-9. Epub 2006 Aug 10.

PMID:
16902054

Supplemental Content

Loading ...
Support Center